BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, Liu M, Wang P, Qiu J, Zhang L, Wu C, Shen H, Wang X, Cheng F, Lu L. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 2022:gutjnl-2021-325150. [PMID: 35140065 DOI: 10.1136/gutjnl-2021-325150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lang H, Zhang H, Ma M, Wan X, Chen Y, sun Q, Cao C. Serum Fstl1, a novel biomarker screened based on protein array technology, predict acute kidney injury and major renal adverse events after cardiac surgery: a prospective cohort study. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.11.008] [Reference Citation Analysis]
2 Qi C, Cao J, Liu X, Chen Q, Liang M, Chen Z, Feng J, Chen B, Ning W, Li L. Follistatin-like 1 mitigates intermittent hypoxia-induced melanoma lung metastasis in mice. Sleep Breath 2022. [DOI: 10.1007/s11325-022-02680-5] [Reference Citation Analysis]
3 Parola M. Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator? Ann Transl Med 2022;10:841. [PMID: 36035001 DOI: 10.21037/atm-22-3561] [Reference Citation Analysis]
4 Xu Y, Chen Y, Zhang X, Ma J, Liu Y, Cui L, Wang F. Glycolysis in Innate Immune Cells Contributes to Autoimmunity. Front Immunol 2022;13:920029. [DOI: 10.3389/fimmu.2022.920029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]